ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA-PRediction in LUng CAncer Treatment) - study protocol.
- DOI
- 10.1136/bmjopen-2025-100311
- Published
- 2026 Feb 2
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-100311,
title = {ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA-PRediction in LUng CAncer Treatment) - study protocol.},
author = {Andersen ME and Nyhus CH and Szejniuk WM and Wahlstrøm S and Timm S and Pallisgaard N and Madsen MG and Mikkelsen MD and Ahlborn LB and Gehl J and Frank MS},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2025-100311},
url = {https://doi.org/10.1136/bmjopen-2025-100311}
}RIS
TY - JOUR TI - ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA-PRediction in LUng CAncer Treatment) - study protocol. AU - Andersen ME AU - Nyhus CH AU - Szejniuk WM AU - Wahlstrøm S AU - Timm S AU - Pallisgaard N AU - Madsen MG AU - Mikkelsen MD AU - Ahlborn LB AU - Gehl J AU - Frank MS PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2025-100311 UR - https://doi.org/10.1136/bmjopen-2025-100311 ER -
APA
ME, A., CH, N., WM, S., S, W., S, T., N, P., MG, M., MD, M., LB, A., J, G., & MS, F. (2026). ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA-PRediction in LUng CAncer Treatment) - study protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2025-100311
Source records
- pubmed · retrieved 2026-09-27T08:41:22.524Z